Aprs 60 ans, les rserves baissent rapidement, augmentant le risque de maladies
J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D
The turning point came around 2015, when higher-dose liraglutide, under the brand name Saxenda, was approved for obesity, confirming the weight loss effect wasnt just a side effect, but a primary therapeutic action. GLP-1s worked differently from earlier diet drugs
Numbness and tingling in the hands or feet can also occur
Investigating the molecular mechanisms enabling TIC growth within 3D gels could unveil new targets to selectively inhibit TIC growth and prevent lymphomagenesis